Overview

Teriparatide for Postsurgical Hypoparathyroidism

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study evaluated the effects of teriparatide (Forteo) on low calcium levels in the setting of thyroid surgery associated with low parathyroid hormone. The hypothesis was that teriparatide ( Forteo) would shorten the length of hospitalization post thyroidectomy in patients with symptomatic hypoparathyroidism.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Teriparatide